Austrian consensus on the definition and treatment of portal hypertension and its complications

Endoscopy

Volumn 37, Issue 7, 2005, Pages 667-673

  Peck Radosavljevic, Markus ^a   Trauner, Michael ^b,m   Schreiber, Florian ^b,m   Angermayr, Bernhard ^a   Arzberger, Erika ^a   Blaha, B ^c   Datz, Ch ^d   Eltschka, Bernhard ^a   Ferlitsch, Arnulf ^a   Gangl, Alfred ^a   Graziadei, Ivo ^e   Gschwantler, Michael ^f   Homoncik, Monika ^a   Judmaier, Gert ^e   Kerstan, Ernst ^c   Kettenbach, Joachim ^g   Laferl, Hermann ^h   Lammer, Johannes ^g   Längle, Friedrich ^a   Lenz, Kurt ⁱ   Maieron, Andreas ^a   Mühlbacher, Ferdinand ^a   Müller, Christian ^a   Munda, Petra ^a   Österreicher, Christian ^j   Ploner, Martin ^a   Püspök, Andreas ^a   Renner, Friedrich ^k   Schmid, Monika ^a   Schöfl, Rainer ^l   Schrutka Kölbl, Christiane ⁿ   Stauber, Rudolf ^m   Steininger, Rudolf ^a   Ulbrich, Gregor ^a   Wichlas, Martina ^a   more..

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c WILHELMINEN HOSPITAL   (Austria)

^d A ö Krankenhaus Oberndorf   (Austria)

^e UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^f Rudolfstiftung   (Austria)

^g UNIV KLIN FÜR RADIODIAGNOSTIK   (Austria)

^h KAISER FRANZ JOSEF HOSPITAL   (Austria)

ⁱ Interne Abteilung   (Austria)

^j HANUSCH HOSPITAL   (Austria)

^k Interne Abteilung A ö KH der Barm Schwestern Renner   (Austria)

^l ELISABETHINEN HOSPITAL   (Austria)

^m UNIVERSITY HOSPITAL GRAZ   (Austria)

ⁿ KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPENICILLIN; ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CEPHALOSPORIN; CLAVULANIC ACID; ISOSORBIDE 5 NITRATE; LACTULOSE; OCTREOTIDE; ORNITHINE ASPARTATE; QUINOLONE; SOMATOSTATIN; TERLIPRESSIN; VASOACTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; ASCITES; AUSTRIA; BACTERIAL INFECTION; BACTERIAL PERITONITIS; CONSENSUS DEVELOPMENT; CONTINUOUS INFUSION; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC VALUE; DISEASE COURSE; DOPPLER FLOWMETRY; ENDOSCOPIC SCLEROTHERAPY; ENDOSCOPIC THERAPY; ESOPHAGUS VARICES BLEEDING; GASTROINTESTINAL ENDOSCOPY; HEPATIC ENCEPHALOPATHY; HEPATORENAL SYNDROME; HUMAN; INCIDENCE; LIVER CIRRHOSIS; LONG TERM CARE; MEDICAL PRACTICE; MEDICAL SOCIETY; NON INVASIVE MEASUREMENT; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; PRACTICE GUIDELINE; PRESSURE GRADIENT; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; RISK REDUCTION; STOMACH ANTRUM VASCULAR ECTASIA; STOMACH DISEASE; STOMACH VARICES;

ASCITES; AUSTRIA; ESOPHAGEAL AND GASTRIC VARICES; HUMANS; HYPERTENSION, PORTAL; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC;

EID: 21644441429     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-861464     Document Type: Article

References (22)

1. de Franchis R. Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 2000; 33: 846-852
2. Moore KP, Wong F, Gines P et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology 2003; 38: 258-266
3. Angermayr B, Cejna M, Peck-Radosavljevic M. Management von Patienten vor und nach Implantation eines transjugulären intrahepatischen portosystemischen Shunts (TIPS) - Bericht der Vienna TIPS Study Group. Journal für Gastroenterologische und Hepatologische Erkrankungen 2003; 1: 11-14
4. Bosch J, Garcia-Pagan JC. Complications of cirrhosis. I. Portal hypertension. J Hepatol 2000; 32: 141-156
5. D'Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis 1999; 19: 475-505
6. Merkel C, Bolognesi M, Sacerdoti D et al. The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology 2000; 32: 930-934
7. Abraldes JG, Tarantino I, Turnes J, Garcia-Pagan JC, Rodes J, Bosch J. Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis. Hepatology 2003; 37: 902-908
8. Garcia-Pagan JC, Morillas R, Banares R et al. Propranolol plus placebo versus propranolol plus isosorbide-5-mononitrate in the prevention of a first variceal bleed: a double-blind RCT. Hepatology 2003; 37: 1260-1266
9. Schepke M, Kleber G, Nurnberg D et al. Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology 2004; 40: 65-72
10. Ben-Ari Z, Cardin F, McCormick AP, Wannamethee G, Burroughs AK. A predictive model for failure to control bleeding during acute variceal haemorrhage. J Hepatol 1999; 31: 443-450
11. Bernard B, Grange JD, Khac EN, Amiot X, Opolon P, Poynard T. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology 1999; 29: 1655-1661
12. Moitinho E, Escorsell A, Bandi JC et al. Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology 1999; 117: 626-631
13. Bureau C, Peron JM, Alric L et al. "A La Carte" treatment of portal hypertension: Adapting medical therapy to hemodynamic response for the prevention of bleeding. Hepatology 2002; 36: 1361-1366
14. Cejna M, Peck-Radosavljevic M, Thurnher S et al. ePTFE-covered stent-grafts for revision of obstructed transjugular intrahepatic portosystemic shunt. Cardiovasc Intervent Radiol 2002; 25: 365-372
15. Angermayr B, Cejna M, Koenig F et al. Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE-covered stent-grafts versus bare stents. Hepatology 2003; 38: 1043-1050
16. Monescillo A, Martinez-Lagares F, Ruiz-del-Arbol L et al. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology 2004; 40: 793-801
17. Primignani M, Carpinelli L, Preatoni P et al. Natural history of portal hypertensive gastropathy in patients with liver cirrhosis. The New Italian Endoscopic Club for the study and treatment of esophageal varices (NIEC). Gastroenterology 2000; 119: 181-187
18. Sarin SK, Lahoti D, Saxena SP, Murthy NS, Makwana UK. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology 1992; 16: 1343-1349
19. Pache I, Bilodeau M. Severe haemorrhage following abdominal paracentesis for ascites in patients with liver disease. Aliment Pharmacol Ther 2005; 21: 525-529
20. Gines P, Cardenas A, Arroyo V, Rodes J. Management of cirrhosis and ascites. N Engl J Med 2004; 350: 1646-1654
21. Rimola A, Garcia-Tsao G, Navasa M et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol 2000; 32: 142-153
22. Sort P, Navasa M, Arroyo V et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999; 341: 403-409